Improved safety of induced pluripotent stem cell-derived antigen-presenting cell-based cancer immunotherapy

The tumorigenicity and toxicity of induced pluripotent stem cells (iPSCs) and their derivatives are major safety concerns in their clinical application. Recently, we developed granulocyte-macrophage colony-stimulating factor (GM-CSF)-producing proliferating myeloid cells (GM-pMCs) from mouse iPSCs a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mashima, Hiroaki, Zhang, Rong, Kobayashi, Tsuyoshi, Tsukamoto, Hirotake, Liu, Tianyi, Iwama, Tatsuaki, Hagiya, Yuichiro, Yamamoto, Masateru, Fukushima, Satoshi, Okada, Seiji, Idiris, Alimjan, Kaneko, Shin, Nakatsura, Tetsuya, Ohdan, Hideki, Uemura, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994724/
https://www.ncbi.nlm.nih.gov/pubmed/33816647
http://dx.doi.org/10.1016/j.omtm.2021.03.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994724/
https://www.ncbi.nlm.nih.gov/pubmed/33816647
http://dx.doi.org/10.1016/j.omtm.2021.03.002

Ejemplares similares